RLRainbow Wing Hung Lau

Rainbow Wing Hung Lau

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rainbow Wing Hung Lau has a total of 93 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Figure 1 from Pulsed Electric Field Ablation Reprograms Tumor Immunity and Stimulates Germinal Center Formation in Tertiary Lymphoid Structures in Patients with Non–Small Cell Lung Cancer

    by Marcelo Jimenez, Beryl A. Hatton, Alicia Moreno-Gonzalez, Jeffrey S. Iding, Javier Flandes, Erik H.F.M. van der Heijden, Calvin S.H. Ng, Carlos Prieto, Cristina Teodosio, Juan A. Flores-Montero, et al.

    Ablation with a specialized form of PEF energy induces a cellular depletion zone (CDZ) devoid of cancer cells, accompanied by TLS presence. A, Ablation needles are placed either via bronchoscopic or percutaneous access with three-dimensional image guidance. Energy delivery results in tumor cell death in the ablation zone. B, Multiple ROIs are defined in histopathologic tissue sections collected from resected tumors after ablation, including the CDZ, a transition zone (TZ) extending beyond the CDZ with a greater density of tumor cells but less than those observed in the remaining tumor (RT), and a peritumoral region extending 1.5 mm beyond the invasive margin of the RT. These four regions are collectively referred to as “TLS-relevant zones.” C, The intent for this study was incomplete ablation for patients in the ablation group. Patients in the control group received only a biopsy, and tumor resection in both groups was approximately 21 days after the biopsy. Representative images from duplex PanCK/CD20, duplex CD4/CD8, and H&E-stained tissue sections are shown. Top left, A whole-tissue image from the resection sample from a nonablated control tumor; (top middle) an example of a preablation biopsy; (top right) the paired resection sample after ablation. The asterisk (*) denotes the approximate location of the CDZ. Scale bars in the top represent 2 mm. The panels below show a representative example of a TLS evident in a resection sample from an ablated tumor. Scale bars represent 100 μm. D, Violin plot showing the total TLS counts by individual tumor for the control (n = 29) and ablation groups (n = 34). The control group (n = 7) was supplemented with additional, nonablated resection samples from patients with characteristics similar to key eligibility criteria who were not enrolled in the study (n = 22; see Supplementary Fig. S3). P values were calculated using the Mann–Whitney test. E, Bar plot demonstrating the percentage of tumors in the ablation group with at least one TLS compared with preablation biopsies. P values were calculated using Fisher's exact test. We additionally compared the proportion of TLS-positive tumors before and after ablation in patients with paired pre- and postablation samples (n = 17) and found a significant difference between the two time points (P < 0.005, calculated using McNemar's χ2 test, data not shown). F, Plot demonstrating the significant difference in TLS count between pre- and postablation tissue samples from patients with paired samples (n = 17). P values were calculated using the Wilcoxon signed-rank test. [Created in BioRender. Pastori, C. (2026) https://BioRender.com/4uwlfv7.].

  • Open Access

    Figure 2 from Pulsed Electric Field Ablation Reprograms Tumor Immunity and Stimulates Germinal Center Formation in Tertiary Lymphoid Structures in Patients with Non–Small Cell Lung Cancer

    by Marcelo Jimenez, Beryl A. Hatton, Alicia Moreno-Gonzalez, Jeffrey S. Iding, Javier Flandes, Erik H.F.M. van der Heijden, Calvin S.H. Ng, Carlos Prieto, Cristina Teodosio, Juan A. Flores-Montero, et al.

    TLS are present regardless of tumor histology and are associated with increased CD8+ lymphocytes in the TME. A, Quantification of TLS in ablated tumors by histologic subtype [ADC (n = 22), mADC (n = 3), LSCC (n = 9)] shows no difference between histologies (P = 0.4653 among the three groups). P values were calculated using the Kruskal–Wallis test with Dunn's multiple comparison test. B, Violin plots demonstrating the total TLS count per zone in ablated tumors (as depicted in Fig. 1B). TLS were identified within all four TLS-relevant zones (P < 0.0001 across the four groups, with significant between-zone differences as specified in the plot), and their accumulation was more robust in the RT and Peri zone. P values were calculated using the Kruskal–Wallis test with Dunn's multiple comparison test. C, A correlation plot of total TLS with respect to the area in mm2 of the ablation zone (CDZ + TZ) indicates a weak positive correlation between total TLS and the ablation zone area (R = 0.4044, P < 0.05). P values were calculated using a nonparametric Spearman correlation. D, The percentage of CD8+ T cells trended toward being increased in ablated tumors compared with control tumors, as measured in relation to all cells within chromogenically stained tissue sections from each group. P values were calculated using the Mann–Whitney test. E, A moderate positive correlation was identified between the total TLS count and the total count of CD8+ T cells within the TLS-relevant zones in postablation resected tumors (R = 0.7027; P < 0.0001). P values were calculated using a nonparametric Spearman correlation. [Created in BioRender. Pastori, C. (2026) https://BioRender.com/0opxod7.].

  • Open Access

    Figure 3 from Pulsed Electric Field Ablation Reprograms Tumor Immunity and Stimulates Germinal Center Formation in Tertiary Lymphoid Structures in Patients with Non–Small Cell Lung Cancer

    by Marcelo Jimenez, Beryl A. Hatton, Alicia Moreno-Gonzalez, Jeffrey S. Iding, Javier Flandes, Erik H.F.M. van der Heijden, Calvin S.H. Ng, Carlos Prieto, Cristina Teodosio, Juan A. Flores-Montero, et al.

    The ablation induces remodeling within the TME that leads to an influx of immune cells. A, t-Distributed stochastic neighbor embedding (t-SNE) plots after clustering analysis based on AbSeq and scRNA-seq, showing shifts in gene expression in the various cell populations within the TME (preablation, n = 20; postablation, n = 25). The annotated subpopulations and classification markers are summarized in Supplementary Table S3. B, The mean percentage of total cells is shown (±SD) for each indicated population from patient samples analyzed by scRNA-seq (preablation, n = 20; postablation, n = 25). P values were calculated using the propeller method. C, Line graph demonstrating the fold change in HMGB1 levels in serum collected within 5 days after ablation relative to baseline in paired samples from the ablation (n = 19) and control groups (n = 2). D, Violin plots demonstrating the mean expression level of Toll-like receptor 2 (TLR2) in neutrophils and cDCs from patient samples analyzed by scRNA-seq (preablation, n = 20; postablation, n = 25). Blue lines represent the median, and P values were calculated using the Wilcoxon rank-sum test. E, Heatmap showing the Z-score for the mean log2 ratio of the fluorescent intensity (FI) cytokine values from postablation samples relative to baseline for serum and tissue cytokines. Cytokines were obtained from serum (n = 33), preablation biopsies (n = 4), and postablation surgical resection samples (n = 16) and analyzed via a multiplexed Luminex assay. Each sample was run in duplicate for each analyte at each time point, and the mean FI was used for analysis relative to baseline levels. Postablation serum samples were collected within 5 days of ablation (early), as well as immediately prior to surgery (resection), and tumor tissue was collected at resection and compared with preablation biopsies. F, Bar plots represent the mean FI (±SD) for the indicated cytokines from preablation biopsies (n = 4) and postablation samples (n = 16). P values were generated using a two-tailed, unpaired t test. G, Violin plots demonstrating the mean expression level of CXCL9 and CXCL10 in the indicated cell populations before ablation (n = 20) and after ablation (n = 25), as analyzed by scRNA-seq. H, Violin plots demonstrating gene expression changes in factors involved in interferon (IFN) responses in neutrophils before ablation (n = 20) and after ablation (n = 25). Asterisks (*) indicate samples for which the adjusted P value was also significant (P < 0.05). cDC, conventional DC. [Created in BioRender. Pastori, C. (2026) https://BioRender.com/a5lhszw.].

  • Open Access

    Data from Pulsed Electric Field Ablation Reprograms Tumor Immunity and Stimulates Germinal Center Formation in Tertiary Lymphoid Structures in Patients with Non–Small Cell Lung Cancer

    by Marcelo Jimenez, Beryl A. Hatton, Alicia Moreno-Gonzalez, Jeffrey S. Iding, Javier Flandes, Erik H.F.M. van der Heijden, Calvin S.H. Ng, Carlos Prieto, Cristina Teodosio, Juan A. Flores-Montero, et al.

    Purpose:This treat-and-resect clinical study evaluated a specialized form of pulsed electric field (PEF) ablation’s potential to modulate antitumor immunity in early-stage non–small cell lung cancer (NSCLC). Tertiary lymphoid structures (TLS) are lymphoid aggregates that recruit immune cells into the tumor microenvironment (TME) and serve as immunity-generating neighborhoods. TLS with germinal centers (GC) have strong prognostic value in most cancers and promote tumor control and responsiveness to immune-based therapies, but no commercially available therapeutics induce their formation. The Aliya System is a proprietary electrosurgical technology that delivers microsecond electrical pulses to tissue, achieving tumor clearance while maintaining stromal architecture. Patients and Methods:Treatment group patients received ablation immediately after diagnostic biopsy versus a biopsy-only control group. Herein, we report on exploratory endpoints examining immune modulation in blood and tumor samples collected from patients in both groups. Results:Histopathologic assessments revealed the presence of TLS with GC in resected tumors. Tissue cytokine assessments and single-cell RNA sequencing demonstrated upregulation of cytokines capable of recruiting and organizing TLS-associated lymphocytes, including CXCL13, and significant increases in GC-related immune populations, including class-switched memory B and plasma cells in ablated tumors versus preablation biopsies. Ablation group patients had more tumors containing TLS with GC (47%) versus control (24%). Ablation group patients exhibited enhanced systemic immunity, with increased serum high mobility group box 1 and circulating cytotoxic T cells. Conclusions:This specialized PEF may orchestrate multiple simultaneous changes that promote a more immunologically active TME and represent a new approach for improving immunotherapeutic regimen responses in patients with NSCLC.

  • Open Access

    Figure 4 from Pulsed Electric Field Ablation Reprograms Tumor Immunity and Stimulates Germinal Center Formation in Tertiary Lymphoid Structures in Patients with Non–Small Cell Lung Cancer

    by Marcelo Jimenez, Beryl A. Hatton, Alicia Moreno-Gonzalez, Jeffrey S. Iding, Javier Flandes, Erik H.F.M. van der Heijden, Calvin S.H. Ng, Carlos Prieto, Cristina Teodosio, Juan A. Flores-Montero, et al.

    Antigen presentation and T-cell activation are accompanied by increased T-cell infiltration and cytotoxic activity after ablation. A, Violin plots demonstrating the mean expression level of IFNGR1 and IFNGR2 in the indicated cell populations before ablation (n = 20) and after ablation (n = 25), as measured by scRNA-seq. Blue lines represent the median, and P values were calculated using the Wilcoxon rank-sum test. B and C, Violin plots demonstrating the mean expression level of various MHC I (B) and MHC II (C) molecules in the indicated cell populations before and after ablation, as measured by scRNA-seq. Asterisks (*) indicate samples for which the adjusted P value was also significant (P < 0.05). D, Heatmap showing the mean log2 fold change in the expression of T-cell activation and effector molecules after ablation (n = 25) relative to preablation (n = 20) as measured by scRNA-seq. E and F, Violin plots demonstrating the mean expression level of cytotoxic effector molecules in cytotoxic T cells (E) and natural killer (NK) cells (F) before ablation (n = 20) and after ablation (n = 25), as measured by scRNA-seq. G, T-cell populations in the TME after ablation, as assessed by scRNA-seq. Bar plots represent the mean percent of each cell population shown relative to the total number of leukocytes in each sample (±SD). P values were calculated using the propeller method. H, FCM analysis of PB lymphocytes from patients who received ablation and no-ablation control patients. The mean number of cells relative to the day 0 biopsy (preablation in the ablation group) is shown (±SD) from available patient samples (control group, n = 6; ablation group, n = 26) that were collected 15–30 days after biopsy/ablation. P values were calculated using the Wilcoxon rank-sum test. No significant difference in the total number of CD45+ cells or the total number of leukocytes was observed before or after ablation or between the control and ablation groups (Supplementary Fig. S8). GZMA, granzyme A; GZMB, granzyme B; Treg, regulatory T cell. [Created in BioRender. Pastori, C. (2026) https://BioRender.com/napu66a.].

  • Open Access

    Supplementary Figures S1-S15 from Pulsed Electric Field Ablation Reprograms Tumor Immunity and Stimulates Germinal Center Formation in Tertiary Lymphoid Structures in Patients with Non–Small Cell Lung Cancer

    by Marcelo Jimenez, Beryl A. Hatton, Alicia Moreno-Gonzalez, Jeffrey S. Iding, Javier Flandes, Erik H.F.M. van der Heijden, Calvin S.H. Ng, Carlos Prieto, Cristina Teodosio, Juan A. Flores-Montero, et al.

    Supplementary Figure 1. CONSORT diagram of patients in the INCITE ES study (NCT04732520) and study schematic. Supplementary Figure 2. Brightfield image analysis pipeline. Supplementary Figure 3. Samples included in the brightfield IHC and multispectral fluorescent IHC analyses Supplementary Figure 4. Comparison of TLS and TLS_GC multispectral immunohistochemistry biomarkers, TLS quantification results from INCITE ES sample groups, and the association of TLS and GC formation with the pathological response to ablation. Supplementary Figure 5. Gating strategy for identification of CD4+ T cell populations by flow cytometry Supplementary Figure 6. Gating strategy for identification of CD8+ T cell populations by flow cytometry Supplementary Figure 7. Gating strategy for identification of B cell populations by flow cytometry. Supplementary Figure 8. Analysis of peripheral blood samples by flow cytometry. Supplementary Figure 9. Histopathological example of the ablation-induced cellular depletion zone (CDZ). Supplementary Figure 10. Ablation induces increased expression of stress response genes. Supplementary Figure 11. Ablation induces increased expression of genes involved in antigen recognition and T lymphocyte activation as well as increased activated and memory T lymphocytes in circulation. Supplementary Figure 12. Genes critical for GC formation and activity are significantly elevated post-ablation Supplementary Figure 13. Ablation does not result in encapsulation around the CDZ. Supplementary Figure 14. Ablation induces a humoral immune response that results in increased serum IgG1, switched memory B cells, and plasmablasts in circulation. Supplementary Figure 15. Off-target responses observed in non-ablated lesions distant from those ablated with the Aliya System in patients not part of the INCITE ES study.

  • Open Access

    Figure 5 from Pulsed Electric Field Ablation Reprograms Tumor Immunity and Stimulates Germinal Center Formation in Tertiary Lymphoid Structures in Patients with Non–Small Cell Lung Cancer

    by Marcelo Jimenez, Beryl A. Hatton, Alicia Moreno-Gonzalez, Jeffrey S. Iding, Javier Flandes, Erik H.F.M. van der Heijden, Calvin S.H. Ng, Carlos Prieto, Cristina Teodosio, Juan A. Flores-Montero, et al.

    Ablation-induced changes in the TME facilitate TLS and GC formation and functional changes suggestive of GC activity. A, B-cell populations in the TME, as assessed by scRNA-seq. Bar plots represent the mean percent of each cell population shown relative to the total number of leukocytes in each sample (±SD). P values were calculated using the propeller method. B, Heatmap showing the mean log2 fold change in the expression of the indicated genes relative to expression levels in naïve B cells as measured by scRNA-seq. C, Representative brightfield IHC images of TLS within an ablated tumor after resection. Example images of TLS_GC are shown, with higher magnification images collected from the areas denoted with dashed boxes. The various cell types within a GC are shown in the high magnification panel, including mature B cells within the GC that exhibit the characteristic morphology of proliferating centroblasts (light blue arrow) and centrocytes (dark green arrow). GCs were also found to contain tingible body macrophages (dark blue arrow) and DCs (black arrow). D, Multispectral immunofluorescent images from the same TLS_GC in C. The first panel shows all biomarkers together [4′,6-diamidino-2-phenylindole (nuclei), CD20, CD4, AID, Ki67, CD21, PNAd], followed by CD20 alone to show B cells, CD4 alone to show T cells, AID and Ki67 together to show proliferating cells and class-switching recombination, and CD21 and PNAd to show FDC networks within the GC and proximal HEV. Scale bars represent 100 μm. E–G, Scatter plots of cell frequencies in all TLS_GC compared with TLS in the ablation group (n = 34), demonstrating the percent of CD20:Ki67 dual-positive B cells (E), CD4:Ki67 dual-positive T cells (F), and CD20:AID dual-positive B cells (G). Blue lines represent the median, and P values were calculated using the Mann–Whitney test. H, Bar plot demonstrating the percentage of ablated tumors (n = 34) containing at least one TLS_GC from the brightfield image assessment, compared with the preablation biopsies (n = 17), as well as to the nonablated tumors from the expanded control group (n = 29; P < 0.0001 across the three groups, with significant between-group differences as specified in the plot). P values were calculated using Fisher's exact test. We additionally compared the proportion of TLS_GC-positive tumors before and after ablation in patients with paired pre- and postablation samples (n = 17) and found a significant difference between the two time points (P < 0.005, calculated using McNemar's χ2 test, data not shown). I, Bar plot demonstrating the percentage of ablated tumors containing at least one TLS_GC from the tissue sections stained with the multispectral immunofluorescent biomarker panel (control, n = 15; preablation, n = 9; postablation, n = 34; P < 0.0001 across the three groups, with significant between-group differences as specified in the plot). P values were calculated using Fisher's exact test. mIHC, multispectral immunohistochemical; TFH, T follicular helper. [Created in BioRender. Pastori, C. (2026) https://BioRender.com/79qnysx.].

  • Open Access

    Supplementary Table S3 from Pulsed Electric Field Ablation Reprograms Tumor Immunity and Stimulates Germinal Center Formation in Tertiary Lymphoid Structures in Patients with Non–Small Cell Lung Cancer

    by Marcelo Jimenez, Beryl A. Hatton, Alicia Moreno-Gonzalez, Jeffrey S. Iding, Javier Flandes, Erik H.F.M. van der Heijden, Calvin S.H. Ng, Carlos Prieto, Cristina Teodosio, Juan A. Flores-Montero, et al.

    Single-Cell RNA Sequencing Cell Classification Scheme

  • Open Access

    Supplementary Table S1 from Pulsed Electric Field Ablation Reprograms Tumor Immunity and Stimulates Germinal Center Formation in Tertiary Lymphoid Structures in Patients with Non–Small Cell Lung Cancer

    by Marcelo Jimenez, Beryl A. Hatton, Alicia Moreno-Gonzalez, Jeffrey S. Iding, Javier Flandes, Erik H.F.M. van der Heijden, Calvin S.H. Ng, Carlos Prieto, Cristina Teodosio, Juan A. Flores-Montero, et al.

    Representativeness of Study Participants

  • Open Access

    Supplementary Table S2 from Pulsed Electric Field Ablation Reprograms Tumor Immunity and Stimulates Germinal Center Formation in Tertiary Lymphoid Structures in Patients with Non–Small Cell Lung Cancer

    by Marcelo Jimenez, Beryl A. Hatton, Alicia Moreno-Gonzalez, Jeffrey S. Iding, Javier Flandes, Erik H.F.M. van der Heijden, Calvin S.H. Ng, Carlos Prieto, Cristina Teodosio, Juan A. Flores-Montero, et al.

    Multispectral Immunofluorescent Antibodies